OBJECTIVE: Children born with asymptomatic congenital cytomegalovirus infection (AcCMV) have increased risk for hearing loss, which may affect their quality of life into adulthood. We aim to determine quality of life outcomes among adults who were identified at birth with AcCMV compared with controls, using the cohort of the Houston Congenital CMV Longitudinal Study. METHODS: Quality of life was determined using the self-reported Quality of Life Inventory (QOLI). Sixty-one of 109 AcCMV subjects and 23 of 51 controls completed QOLI. Percentile scores of subjects were compared with percentile scores of controls using Student t tests. QOLI percentile scores were compared among AcCMV subjects with (N = 14) and without hearing loss (N = 47). RESULTS: There was no difference in mean percentile scores on QOLI between AcCMV subjects (59.8 [SD = 27.6]) and controls (57.3 [SD = 35.3]; p = 0.754). Percentile scores indicate an average overall quality of life classification for AcCMV subjects and controls. There was no difference in mean percentile scores on the QOLI between AcCMV subjects with and without hearing loss (54.8 [SD = 25.2]) and 61.3 [SD = 28.3]; p = 0.440, respectively). CONCLUSION: Adults born with AcCMV do not seem to have lower ratings of quality of life compared with uninfected controls. Although our study had small sample size, hearing loss does not seem to be a significant predictor of QOLI percentile scores among AcCMV subjects. Quality of life in adulthood does not seem to be affected by an individual's awareness of screening positive for CMV, which supports the notion of "no harm" occurring from universal newborn screening for congenital CMV infection.
OBJECTIVE: Children born with asymptomatic congenital cytomegalovirus infection (AcCMV) have increased risk for hearing loss, which may affect their quality of life into adulthood. We aim to determine quality of life outcomes among adults who were identified at birth with AcCMV compared with controls, using the cohort of the Houston Congenital CMV Longitudinal Study. METHODS: Quality of life was determined using the self-reported Quality of Life Inventory (QOLI). Sixty-one of 109 AcCMV subjects and 23 of 51 controls completed QOLI. Percentile scores of subjects were compared with percentile scores of controls using Student t tests. QOLI percentile scores were compared among AcCMV subjects with (N = 14) and without hearing loss (N = 47). RESULTS: There was no difference in mean percentile scores on QOLI between AcCMV subjects (59.8 [SD = 27.6]) and controls (57.3 [SD = 35.3]; p = 0.754). Percentile scores indicate an average overall quality of life classification for AcCMV subjects and controls. There was no difference in mean percentile scores on the QOLI between AcCMV subjects with and without hearing loss (54.8 [SD = 25.2]) and 61.3 [SD = 28.3]; p = 0.440, respectively). CONCLUSION: Adults born with AcCMV do not seem to have lower ratings of quality of life compared with uninfected controls. Although our study had small sample size, hearing loss does not seem to be a significant predictor of QOLI percentile scores among AcCMV subjects. Quality of life in adulthood does not seem to be affected by an individual's awareness of screening positive for CMV, which supports the notion of "no harm" occurring from universal newborn screening for congenital CMV infection.
Authors: Michael B Frisch; Michelle P Clark; Steven V Rouse; M David Rudd; Jennifer K Paweleck; Andrew Greenstone; David A Kopplin Journal: Assessment Date: 2005-03
Authors: Linda D Breeman; Sylvia van der Pal; Gijsbert H W Verrips; Nicole Baumann; Peter Bartmann; Dieter Wolke Journal: Qual Life Res Date: 2016-09-22 Impact factor: 4.147
Authors: Adriana S Lopez; Tatiana M Lanzieri; Angelika H Claussen; Sherry S Vinson; Marie R Turcich; Isabella R Iovino; Robert G Voigt; A Chantal Caviness; Jerry A Miller; W Daniel Williamson; Craig M Hales; Stephanie R Bialek; Gail Demmler-Harrison Journal: Pediatrics Date: 2017-11 Impact factor: 7.124
Authors: Soren Gantt; Francois Dionne; Fred K Kozak; Oran Goshen; David M Goldfarb; Albert H Park; Suresh B Boppana; Karen Fowler Journal: JAMA Pediatr Date: 2016-12-01 Impact factor: 16.193
Authors: Ingrid Marie Husby; Kaia Mølbach-Thellefsen Stray; Alexander Olsen; Stian Lydersen; Marit Sæbø Indredavik; Ann-Mari Brubakk; Jon Skranes; Kari Anne I Evensen Journal: Health Qual Life Outcomes Date: 2016-04-07 Impact factor: 3.186
Authors: T M Lanzieri; J Leung; A C Caviness; W Chung; M Flores; P Blum; S R Bialek; J A Miller; S S Vinson; M R Turcich; R G Voigt; G Demmler-Harrison Journal: J Perinatol Date: 2017-04-06 Impact factor: 2.521
Authors: M J Korndewal; A C T M Vossen; J Cremer; R S VAN Binnendijk; A C M Kroes; M A B VAN DER Sande; A M Oudesluys-Murphy; H E DE Melker Journal: Epidemiol Infect Date: 2015-11-11 Impact factor: 4.434